Global Cord Blood Corporation
Global Cord Blood Corporation (CORBF) Revenue
Annual & quarterly revenue history · segment & region breakdown
CORBF · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsGlobal Cord Blood Corporation trailing twelve-month (TTM) revenue is $1.23B, an increase of 0.00% year-over-year from — in FY.
Revenue trend
– · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Global Cord Blood Corporation receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Global Cord Blood Corporation reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Global Cord Blood Corporation's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
CORBF revenue · 4 questionsCORBF's trailing twelve-month (TTM) revenue is $1.23B. That is an increase of 0.00% year-over-year from — in FY.
▸ Source: FMP · Global Cord Blood Corporation SEC filings · GAAP · Global Cord Blood Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026